{
     "PMID": "21470858",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20110823",
     "LR": "20110502",
     "IS": "1464-3405 (Electronic) 0960-894X (Linking)",
     "VI": "21",
     "IP": "10",
     "DP": "2011 May 15",
     "TI": "Radiosynthesis and preliminary evaluation of 4-[18F]fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylb enzamide as a new positron emission tomography ligand for metabotropic glutamate receptor subtype 1.",
     "PG": "2998-3001",
     "LID": "10.1016/j.bmcl.2011.03.046 [doi]",
     "AB": "The purpose of this study was to develop 4-[(18)F]fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methy lbenzamide ([(18)F]FITM, [(18)F]4) as a new PET ligand for imaging metabotropic glutamate receptor subtype 1 (mGluR1). [(18)F]4 was synthesized by [(18)F]fluorination of a novel nitro precursor 3 with [(18)F]KF in the presence of Kryptofix 222. At the end of synthesis, 429-936 MBq (n=8) of [(18)F]4 was obtained with >99% radiochemical purity and 204-559GBq/mumol specific activity starting from 6.7 to 13.0 GBq of [(18)F]F(-). The brain distribution of [(18)F]4 was determined by the in vitro and ex vivo autoradiography using rat brain sections. The in vitro and in vivo specific binding of [(18)F]4 to mGluR1 was detected in the cerebellum, thalamus, hippocampus, and striatum. These results suggest that [(18)F]4 is a promising PET ligand for the in vivo evaluation of mGluR1.",
     "CI": [
          "Copyright (c) 2011 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Yamasaki, Tomoteru",
          "Fujinaga, Masayuki",
          "Yoshida, Yuichiro",
          "Kumata, Katsushi",
          "Yui, Joji",
          "Kawamura, Kazunori",
          "Hatori, Akiko",
          "Fukumura, Toshimitsu",
          "Zhang, Ming-Rong"
     ],
     "AU": [
          "Yamasaki T",
          "Fujinaga M",
          "Yoshida Y",
          "Kumata K",
          "Yui J",
          "Kawamura K",
          "Hatori A",
          "Fukumura T",
          "Zhang MR"
     ],
     "AD": "Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Chiba 263-8555, Japan.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20110317",
     "PL": "England",
     "TA": "Bioorg Med Chem Lett",
     "JT": "Bioorganic & medicinal chemistry letters",
     "JID": "9107377",
     "RN": [
          "0",
          "(4-fluoro-N-(4-(6-(isopropylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)-N-methylbenza",
          "mide)",
          "0 (Benzamides)",
          "0 (Ligands)",
          "0 (Radiopharmaceuticals)",
          "0 (Receptors, Metabotropic Glutamate)",
          "0 (Thiazoles)",
          "0 (metabotropic glutamate receptor type 1)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Benzamides/*chemical synthesis/chemistry/*metabolism",
          "Brain/metabolism",
          "Inhibitory Concentration 50",
          "*Ligands",
          "Molecular Structure",
          "Positron-Emission Tomography/methods",
          "*Radiopharmaceuticals/chemical synthesis/metabolism",
          "Rats",
          "*Receptors, Metabotropic Glutamate/analysis/metabolism",
          "Thiazoles/*chemical synthesis/chemistry/*metabolism"
     ],
     "EDAT": "2011/04/08 06:00",
     "MHDA": "2011/08/24 06:00",
     "CRDT": [
          "2011/04/08 06:00"
     ],
     "PHST": [
          "2011/01/31 00:00 [received]",
          "2011/03/10 00:00 [revised]",
          "2011/03/11 00:00 [accepted]",
          "2011/04/08 06:00 [entrez]",
          "2011/04/08 06:00 [pubmed]",
          "2011/08/24 06:00 [medline]"
     ],
     "AID": [
          "S0960-894X(11)00365-9 [pii]",
          "10.1016/j.bmcl.2011.03.046 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Bioorg Med Chem Lett. 2011 May 15;21(10):2998-3001. doi: 10.1016/j.bmcl.2011.03.046. Epub 2011 Mar 17.",
     "term": "hippocampus"
}